Advertiser Disclosure

advertising disclaimer
Skip to main content
pill

Pfizer's COVID-19 Pill Could Be Here By Year-End: Investor Impact


May 03, 2021 by Maurie Backman
Get our 43-Page Guide to Real Estate Investing Today!

Real estate has long been the go-to investment for those looking to build long-term wealth for generations. Let us help you navigate this asset class by signing up for our comprehensive real estate investing guide.

*By submitting your email you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions.

Ever since the coronavirus pandemic began, many people have wondered -- was it really necessary to shut down society when we don't go the same route for the flu?

But there are a number of key differences between COVID-19 and influenza. First, flu vaccines have long been in circulation, so that protection has been available for a while. Secondly, there actually is effective, at-home treatment for the flu that can prevent those infected from becoming severely ill, whereas there's no such easy treatment for COVID-19.

But now, things are changing on the coronavirus front. Vaccines, which were slow to reach the public earlier this year, are now widely available, which means more people can roll up their sleeves and get jabbed into immunity. But on top of that, there's reason to believe we may have an effective at-home treatment for COVID-19 that could make it a much less substantial threat.

A pill to treat COVID-19 may be on its way

In late April, Pfizer (NYSE: PFE), which introduced one of the three vaccine formulas currently on the market, announced its oral drug to treat COVID-19 at the first sign of illness may be available to the public by the end of the year. Though the company is still in the process of testing that drug via clinical trials, CEO Albert Bourla is optimistic about it hitting the market before 2021 comes to a close.

If the new pill is proven to be safe and effective, it could result in much less severe illness for those who do become infected with COVID-19. It could also keep a lot of people out of hospitals, thereby avoiding scenarios where healthcare systems are overburdened. Just as importantly, if people don't need to leave the house to receive coronavirus treatment, they may largely avoid spreading the virus to others.

Positive news for real estate investors

A simple at-home coronavirus pill would clearly be great news for the public as a whole. But it could also benefit real estate investors in a very meaningful way.

Much of society has been shuttered for the past year due to coronavirus concerns. But if a new at-home treatment becomes available, the virus itself will be less of a threat. That means businesses may be able to open up fully and restrictions can be lifted. The result? Fewer closures, and fewer vacancies for commercial landlords to have to worry about.

Reopening society could also work wonders for office REITs (real estate investment trusts), which have been sluggish since the remote work trend kicked off. Similarly, the sooner we can get back to normal, the sooner travel will open up even more, thereby helping hotels dig out of their current hole.

The Millionacres bottom line

Of course, an at-home COVID-19 pill isn't the only thing Pfizer is testing these days. The pharma giant is also in the process of testing out its vaccine on younger children in the hopes that they'll be eligible for it soon enough. Right now, the youngest age to get a coronavirus vaccine is 16. If vaccines open up to children of all ages, that, combined with a home-based COVID-19 treatment that turns the virus into a run-of-the-mill, short-term illness, could really help the U.S. move past the pandemic once and for all.

Unfair Advantages: How Real Estate Became a Billionaire Factory

You probably know that real estate has long been the playground for the rich and well connected, and that according to recently published data it’s also been the best performing investment in modern history. And with a set of unfair advantages that are completely unheard of with other investments, it’s no surprise why.

But those barriers have come crashing down - and now it’s possible to build REAL wealth through real estate at a fraction of what it used to cost, meaning the unfair advantages are now available to individuals like you.

To get started, we’ve assembled a comprehensive guide that outlines everything you need to know about investing in real estate - and have made it available for FREE today. Simply click here to learn more and access your complimentary copy.

Maurie Backman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.